Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort

Fig. 3

Shows the individual absolute differences of 10 study participants in the GMFM-88 assessments at start of trial, end of trial and end of follow up period. 2 children started with a maximum of 100 % in the GMFM-88 and maintained their mobility levels over the whole observation period. Therefore no changes are detectable in these 2 children (marked by the asterisk) lying on the dotted line which marks the line of no difference

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172